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PHARMACIST LIABILITY: THE DOORS OF
LITIGATION ARE OPENING
R. Paul Asbury*
I. INTRODUCTION
"Danger at the drugstore: Too many pharmacists fail to
protect consumers against potentially hazardous interactions
of prescription drugs."1
Headlines such as this from U.S. News & World Report
indicate an increasing awareness that pharmacists have a
much greater role in health care today than ever before.2 The
days when a pharmacist's sole duty consisted of accurately
filling and dispensing prescriptions are gone.3 Today, phar-
macists take on a more active role in the health care system,4
encompassing more responsibilities and consequently greater
liabilities.5
Until recently, successful litigation against pharmacists
who correctly filled prescriptions was virtually nonexistent.6
Attempts to impose liability upon pharmacists under theories
of strict liability,7 duty to warn,8 and breach of warranty9 were
* Technical Editor, Santa Clara Law Review, Volume 40. J.D. candidate,
Santa Clara University School of Law; PharmD., University of California, San
Francisco; B.A., University of California, Santa Cruz. The author has worked
as a pharmacist for 18 years.
1. Susan Headden et al., Danger at the Drugstore, U.S. NEWS & WORLD
REPORT, Aug. 26, 1996, at 46.
2. See id.
3. See Terence C. Green, Licking, Sticking, Counting, and Pouring-Is
That All Pharmacists Do? McKee v. American Home Products Corp., 24
CREIGHTON L. REV. 1449 (1991).
4. See discussion infra Part H.B.
5. See discussion infra Part IV.
6. See discussion infra Part H.A.
7. See discussion infra Part I1.A.2.
8. See discussion infra Part H.A.3.
9. See discussion infra Part H.A.4.
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largely unsuccessful. ° However, recent changes in legisla-
tion,1" case law,12 and pharmacists' new role in health care 3
have increased pharmacists' liabilities. 4
In 1990, Congress enacted the Omnibus Budget Recon-
ciliation Act ("OBRA 90"), which codified the duties of phar-
macists and required states to implement new programs to
provide better patient care." OBRA 90 requires pharmacists
to monitor patients' drug therapy, intervene (i.e., suggest
changes to drug therapy to optimize patient care) when nec-
essary, and provide patient education prior to dispensing pre-
scriptions. 6
In 1994, the Arizona Court of Appeals asserted that the
prior "no duty to warn" cases were wrongly decided. In
Lasley v. Shrake's Country Club Pharmacy, Inc., 8 the court
concluded that the prior courts had misinterpreted the
meaning of the duty to warn and confused it with the phar-
macist's standard of care. 9 Two years later, in Baker v. Arbor
Drugs, Inc.," the Michigan Court of Appeals ruled that a
pharmacy may voluntarily assume a duty to warn its custom-
ers. " In Baker, the court held that the defendant pharmacy
had voluntarily assumed a duty to warn and to prevent harm-
ful drug interactions when it advertised and promoted this
10. See discussion infra Part II.A.2-4.
11. See discussion infra Part lI.B.3.
12. See discussion infra Part II.B.1.
13. See discussion infra Part I.B.4.
14. See discussion infra Part II.B.
15. See Omnibus Budget Reconciliation Act of 1990, Pub. L. No. 101-508,
104 Stat. 1388 (codified in scattered sections of 42 U.S.C.).
16. See 42 U.S.C. § 1396r-8(g)(1)(A) (1994).
17. See Lasley v. Shrake's Country Club Pharmacy, Inc., 880 P.2d 1129
(Ariz. Ct. App. 1994).
18. Id. at 1132.
In response to Shrake's motion to dismiss, appellants presented an af-
fidavit from an expert stating that the standard of care applicable to a
pharmacist includes a responsibility to advise a customer of the addic-
tive nature of a drug, to warn of the hazards of ingesting two or more
drugs that adversely interact with one another, and to discuss with the
physician the addictive nature of a prescribed drug and the dangers of
long-term prescription of the drug.
Id. at 1134.
19. See id. The court concluded that pharmacists owe a duty of reasonable
care and left it for the trial court to determine what standard of care to apply.
See id. at 1132-33.
20. Baker v. Arbor Drugs, Inc., 544 N.W.2d 727 (Mich. Ct. App. 1996).
21. See id. at 731.
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ability to its customers.2 These recent court decisions, as
well as the expanding role of pharmacists in health care to-
day,' demonstrate the need for courts to reevaluate the tradi-
tional limits on pharmacist liability.
24
Part II of this comment traces pharmacist liability from
its traditional bases' to the most recent court decisions.26
Part III presents the issue of whether to expand pharmacist
liability based on the changes in the pharmacy profession. 7
Part IV provides an analysis of recent changes in case law,'
pharmacy law, 9 and the pharmacy profession0 that contrib-
ute to the increase in pharmacists' liability. Consistent with
the active role pharmacists perform in health care delivery
today,31 Part V proposes abandoning the traditional limits on
pharmacist liability.
II. BACKGROUND
A. The Traditional Role and Liability of Pharmacists
Pharmacists have always occupied an important position
in the drug distribution system by ensuring the accurate de-
livery of prescription drugs.2 The need for accuracy resulted
in pharmacist liability as a matter of law for errors in filling
prescriptions. However, courts have traditionally found no
pharmacist liability when a prescription is filled accurately.33
This section discusses the traditional bases of pharmacist
liability: no strict liability, no liability for a pharmacist's fail-
ure to warn of a drug's adverse effects, and no liability under
breach of warranty theories.34 Next, this section addresses
the recent case law and legislation that attack the traditional
22. See id.
23. See discussion infra Part II.B.4.
24. See discussion infra Part II.A.
25. See discussion infra Part II.A.
26. See discussion infra Part II.B.1-2.
27. See discussion infra Part H.
28. See discussion infra Part IV.C.
29. See discussion infra Part W.C.1.
30. See discussion infra Part IV.
31. See discussion infra Part IV.
32. See David B. Brushwood, The Professional Capabilities and Legal Re-
sponsibilities of Pharmacists: Should "Can" Imply "Ought"?, 44 DRAKE L. REV.
439 (1996).
33. See id.
34. See discussion infra Part II.A.2-4.
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notions of pharmacist liability by finding pharmacists liable
for failure to warn of adverse drug effects."5 Finally, this sec-
tion examines the changing role of pharmacists in health care
today and the effects of that change on pharmacists' liabil-
ity.
3 6
1. Pharmacists Are Liable as a Matter of Law for Errors
Filling Prescriptions
Traditionally, pharmacists were responsible for the accu-
rate processing of prescription orders-assuring that the
right patient receives the correct drug, dosage, and directions
for use." This technical approach reflects the lack of inde-
pendent judgment in the pharmacist's traditional role by
holding pharmacists liable for all errors made when filling
prescriptions.38 This traditional role of pharmacists usually
results in negligence as a matter of law for any such errors.39
In an oft-cited 1971 wrongful birth case, Troppi v. Scarf,"
a pharmacist negligently filled a prescription for birth control
pills with the wrong medication.41 As a result of this error,
the plaintiff became pregnant and gave birth to a healthy
child.42 The Michigan Court of Appeals held that the pharma-
cist had an absolute duty to dispense the correct drug, and
was therefore liable for the "harm" resulting from dispensing
the wrong medication.43
Courts also recognize that, in addition to filling prescrip-
tions without error, a pharmacist may have a duty to verify,
or refuse to fill, a prescription that contains a patent or obvi-
ous error on its face." In Nichols v. Central Merchandise,45 a
Kansas appellate court stated that a pharmacist has a duty
not only to fill prescriptions accurately, but also to be alert for
35. See discussion infra Part II.B.1-2.
36. See discussion infra Part lI.B.3-4.
37. See Brushwood, supra note 32, at 443.
38. See id.
39. See DeCordova v. State, 878 P.2d 73, 76 (Colo. Ct. App. 1994).
40. Troppi v. Scarf, 187 N.W.2d 511 (Mich. Ct. App. 1971).
41. See id. at 512.
42. See id. at 513.
43. See id.
44. See, e.g., McKee v. American Home Prods. Corp., 782 P.2d 1045, 1049
(Wash. 1989).
45. Nichols v. Central Merchandise, Inc., 817 P.2d 1131 (Kan. Ct. App.
1991).
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clear errors or mistakes on the face of a prescription.46 Ac-
cording to the Nichols court, because there were no clear er-
rors on the face of the plaintiffs prescription, such as inade-
quate instructions or an inappropriate medication, the
pharmacist did not violate any legal duties to the patient.47
2. No Strict Liability for Injuries When a Prescription Is
Accurately Filled
A majority of courts refuse to hold pharmacists who accu-
rately fill prescriptions strictly liable for injuries to patients
caused by defective drugs.48 Prescription medications, as con-
sumer products, traditionally have been viewed as an excep-
tion to the usual product liability rules.49 Product liability in
drug injury cases is usually characterized by substantial def-
erence to both drug manufacturers and pharmacies." The
courts justify their deferential treatment of pharmacies by de-
fining pharmacists as service providers of drugs, as opposed
to retail sellers of drugs.51 Historically, courts usually exempt
service providers from the rigors of strict liability.52
In addition to classifying pharmacists as service provid-
ers and not sellers of medications, courts compare pharma-
cists to drug manufacturers, who are not subject to strict li-
ability.53 Pharmacists, as suppliers, cannot choose what drug
to make available to consumers, nor can patients, as consum-
ers, freely choose which drug to buy.' In the restricted dis-
46. See id. at 1133.
47. See id. at 1133-34.
48. See, e.g., Leesley v. West, 518 N.E.2d 758, 762 (IM. App. Ct. 1988) (con-
cluding strict liability upon pharmacist to be illogical and inequitable); Kampe
v. Howard Stark Profl Pharmacy, Inc., 841 S.W.2d 223 (Mo. Ct. App. 1992)
(holding that a pharmacist's duty is fulfilled by properly filling a legally written
prescription); Batiste v. American Home Prods. Corp., 231 S.E.2d 269, 275 (N.C.
Ct. App. 1977) (refusing to apply strict liability for injuries resulting from the
use of a drug that was dispensed in strict compliance with the physician's or-
der).
49. See Jeffrey N. Gibbs & Bruce F. Mackler, Food and Drug Administra-
tion Regulation and Products Liability: Strong Sword, Weak Shield, 22 TORT &
INS. L.J. 194, 200-01 (1987).
50. See id. at 199-201.
51. See McLeod v. W.S. Merrell Co., 167 So. 2d 901, 903 (Fla. Dist. Ct. App.
1964) (holding that a pharmacist performs a service as opposed to a sale).
52. See Leesley, 518 N.E.2d at 762; Kampe, 841 S.W.2d at 223; Batiste, 231
S.E.2d at 275.
53. See Coyle v. Richardson-Merrell, Inc., 584 A.2d 1383, 1386 (Pa. 1991).
54. See id.
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tribution system of prescription drugs, the public is not forced
to rely on pharmacists to obtain the products it needs."5
Finally, patients rely on their physicians to assess the
risks inherent in prescription drugs." Since a pharmacist
cannot substitute his judgment for that of the physician,
holding pharmacists strictly liable would provide no safety in-
centive for patients.57 Pharmacists' lack of influence over the
marketing of prescription drugs argues against strict liability,
which assumes that retailers pressuring manufacturers will
provide safety incentives. Thus, when a pharmacist dis-
penses medication in accordance with a validly written pre-
scription, and such medication causes injury to a patient due
to a defect, the pharmacist usually avoids strict liability.59
3. No Duty to Warn of a Medication's Adverse Effects
In addition to the service provider exception for pharma-
cists," two rules limit applying strict liability to pharmacists
who accurately fill prescriptions. The first is the prescription
drug exception for products considered "unavoidably unsafe."
The second is the learned intermediary doctrine, which ex-
empts both pharmacists and drug manufacturers from liabil-
ity for failure to warn and places upon prescribing physicians
the responsibility of warning patients of the potential risks of
a prescription drug.61 The drafters of the Restatement of
55. See id.
56. See id.
57. See id. at 1138.
58. See generally, David B. Brushwood & Richard R. Abood, Strict Liability
in Tort: Appropriateness of the Theory for Retail Pharmacists, 42 FOOD DRUG
COSM. L.J. 269 (1987).
59. Although the American Law Institute provides for strict liability of the
seller of a product in the Restatement (Second) of Torts section 402A, com-
ment k to section 402A provides an exception for retail pharmacists. Comment
k provides: "There are some [drugs] which, in the present state of human
knowledge, are quite incapable of being made safe for their intended and ordi-
nary use ... Such a product, properly prepared, and accompanied by proper di-
rections and warning, is not defective, nor is it unreasonably dangerous."
REsTATEMENT (SECOND) OF TORTS § 402A cmt. k (1965). As such, the seller of
such a product will avoid strict liability. Comment k effectively provides a de-
fense for manufacturers as well as any other "sellers" of unavoidably unsafe
drugs. See id.
60. See Leesley v. West, 518 N.E.2d 758, 762 (Ill. App. Ct. 1988); Kampe v.
Howard Stark Profl Pharmacy, Inc., 841 S.W.2d 223 (Mo. Ct. App. 1992); Ba-
tiste v. American Home Prods. Corp., 231 S.E.2d 269, 275 (N.C. Ct. App. 1977).
61. See Kathy Laughter Laizure, Note, The Pharmacist's Duty to Warn
When Dispensing Prescription Drugs: Recent Tennessee Developments, 22 MEM.
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Torts created the unavoidably unsafe exception out of defer-
ence to vital medications, such as antibiotics and vaccines,
that offer substantial benefits to public health.62 The learned
intermediary doctrine derives from the theory that physicians
are in the best position to choose the appropriate medication
and advise patients of the inherent risks of treatment.63
Applying the unavoidably unsafe exception and the
learned intermediary doctrine, most courts find that pharma-
cists owe no duty to warn patients of the inherent risks of
drugs.' The majority of courts identify physicians, the
learned intermediaries between manufacturers and patients,
as the proper medical professionals to warn patients of the
possible risks of prescription drugs. 5 Thus, the sole obliga-
tion of pharmacists is merely to dispense prescriptions accu-
rately,66 with the absence of any error effectively immunizing
pharmacists from liability.
a. The Stebbins Case
In the 1987 case of Stebbins v. Concord Wrigley Drugs,
Inc.,68 the plaintiff alleged that she sustained injuries as a re-
sult of the failure of a physician and pharmacist to warn her
of the sedative side effects of a prescribed medication.69 The
court affirmed summary judgment of the negligence claim in
favor of the pharmacy on the grounds that the dispensing
ST. U. L. REV. 517, 522-26 (1992).
62. See RESTATEMENT (SECOND) OF TORTS § 402A cmt. k.
63. See Gibbs & Mackler, supra note 49, at 198.
64. See Pysz v. Henry's Drug Store, 457 So. 2d 561, 562 (Fla. Dist. Ct. App.
1984) (holding that it is the physician's duty to know the drug and properly
monitor the patient); Leesley, 518 N.E.2d at 763 (declining to subject pharma-
cists to liability for failing to give warnings when a physician has not requested
warnings); Adkins v. Mong, 425 N.W.2d 151, 154 (Mich. Ct. App. 1988) (con-
cluding a pharmacist has no duty to monitor or intervene with a customer's re-
liance on drugs prescribed by a physician); Stebbins v. Concord Wrigley Drugs,
Inc., 416 N.W.2d 381, 387-88 (Mich. Ct. App. 1987) (holding a pharmacist owes
no duty to warn of possible side effects of a prescription where the prescription
is proper on its face and neither the physician nor manufacturer has required
any warning be given to the patient by the pharmacist).
65. See supra note 64.
66. See Stebbins, 416 N.W.2d at 387-88.
67. See Leesley, 518 N.E.2d at 760 (applying the learned intermediary doc-
trine to pharmacists); Batiste v. American Home Prods. Corp., 231 S.E.2d 269,
274 (N.C. Ct. App. 1977) (holding that without an allegation that the drug dis-
pensed differed from the drug prescribed, the pharmacist escapes liability).
68. Stebbins, 416 N.W.2d at 381.
69. See id. at 383.
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pharmacist had no duty to warn the plaintiff of the potential
side effects of the drug.7" Finding no authority within its ju-
risdiction regarding a pharmacist's duty to warn patients di-
rectly, the court relied on other jurisdictions' failure to impose
such a duty in granting summary judgement.71
b. The Adkins Case
Generally, the physician is still viewed as the only health
care professional with the duty to warn.72 In Adkins v.
Mong,7" the plaintiff alleged negligence and malpractice on
the part of a pharmacist for supplying the plaintiff with ex-
cessive amounts of prescription drugs over a six-year period,
which resulted in severe drug addiction.74 The plaintiff as-
serted that the pharmacist's failure to warn of the addictive
nature of the drugs resulted in his addiction.75 Further, the
plaintiff claimed the pharmacist had a duty to monitor pa-
tients. Specifically, the plaintiff alleged that the pharmacist
should maintain a detailed and accurate patient profile, use
this profile to identify addicted customers, and act on this in-
formation by either refusing to fill prescriptions, notifying the
physician, or warning the customer.7"
The Adkins court looked to other jurisdictions to address
the issue of whether the pharmacist owed such a duty.77 The
court concluded that other jurisdictions consistently reject the
existence of this duty, holding that pharmacists owe no duty
to warn.78 The court held that "there exists no legal duty on
the part of a pharmacist to monitor and intervene with a cus-
tomer's reliance on drugs prescribed by a licensed treating
physician.
79
70. See id. at 387.
71. See id. (conceding that while a pharmacist may have greater knowledge
of a drug's propensities, it is still the physician's duty to know the drug pre-
scribed and to monitor and warn).
72. See id.
73. Adkins v. Mong, 425 N.W.2d 151 (Mich. Ct. App. 1988).
74. See id. at 152.
75. See id.
76. See id.
77. See id. at 152-53.
78. See id. at 154.
79. Adkins, 425 N.W.2d at 154.
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c. The McKee Case
A year later, based on facts similar to Adkins, the court
in McKee v. American Home Products Corp.0 held that a
pharmacist who accurately filled a prescription issued by a
licensed physician had no duty to warn the customer of the
potential hazards associated with the drug.8' The plaintiff in
McKee brought a negligence action against pharmacists who
correctly filled her validly written prescriptions for ampheta-
mines over the course of a ten-year period.82 The plaintiff as-
serted that the pharmacists were negligent for dispensing the
drugs over such an extended period of time without warning
her of the serious side effects, including the drug's abuse and
addictive potential.83
The McKee court took the position that a supplier of
drugs has no "duty to question a judgment made by the phy-
sician as to the propriety of a prescription or to warn custom-
ers of the hazardous side effects associated with a drug.'
The court held that under the learned intermediary doc-
trine,' the physician, rather than the pharmacist, should (1)
be aware of the risks and benefits of drug therapy, (2) use this
knowledge to determine the best course of therapy for the pa-
tient, and (3) apprise the patient of any potential hazards of
therapy.88 Further, the court noted that imposing a duty to
warn upon pharmacists would (1) impose liability on pharma-
cists who have no legal authority to select the appropriate
drug therapy for patients, (2) force pharmacists to intervene
in matters where only physicians are competent, and (3) in-
terfere with the physician-patient relationship by requiring
pharmacists to practice medicine without a license.
Finding no general duty to warn, the McKee court ad-
dressed whether actual or constructive knowledge of the in-
appropriateness of prolonged drug treatment should affect
the duty to warn." While the court found that pharmacists
80. McKee v. American Home Prods. Corp., 782 P.2d 1045 (Wash. 1989).
81. See id. at 1055-56.
82. See id. at 1047.
83. See id.
84. Id. at 1055-56.
85. See Leesley v. West, 518 N.E.2d 758, 760 (Ill. App. Ct. 1988).
86. See McKee, 782 P.2d at 1049-50.
87. See id. at 1050-53.
88. See id. at 1052.
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should be alert for obvious or known errors in a prescription,89
it recognized that without access to a patient's complete
medical history, a pharmacist may not know that a particular
drug is contraindicated." Further, the court emphasized that
without the benefit of this medical history, a pharmacist can-
not determine the propriety of a particular drug regimen.9 1
Finally, the court stated that the duty to warn a patient of
the dangerous propensities of a prescription drug rests solely
with the prescribing physician, not the pharmacist.92
d. The Coyle Case
In Coyle v. Richardson-Merrell, Inc.," a 1991 case reject-
ing the pharmacist's duty to warn, the plaintiffs argued that
their pharmacist had a duty to warn them about the potential
birth defects associated with an anti-nausea drug used during
pregnancy.94 In rejecting the duty to warn, the court stated:
While the patient is entitled to know, and a doctor has a
duty to inform the patient of any dangers or side effects
associated with a drug recommended for treatment, we see
no sound reason for imposing on pharmacists the duty to
supply information about the risks of drugs that have al-
ready been prescribed. On the contrary, such a rule would
have the effect of undermining the physician-patient rela-
tionship by engendering fear, doubt, and second-
guessing.
95
89. See id. Examples of patent errors pharmacists should be aware of in-
clude "obvious lethal dosages, inadequacies in instructions, known contraindica-
tions, or incompatible prescriptions." Id. at 1053 (citations omitted).
90. See id. at 1053. A contraindication is "any condition which renders a
particular line of treatment improper or undesirable." DORLAND'S POCKET
MEDICAL DICTIONARY 166 (23d ed. 1982).
91. See McKee, 782 P.2d at 1053.
A prescription which is excessive for one patient may be entirely rea-
sonable for the treatment of another. To fulfill the duty which the
plaintiff urges us to impose would require the pharmacist to learn the
customer's condition .... To accomplish this, the pharmacist would
have to inteject himself into the doctor-patient relationship and prac-
tice medicine without a license.
Id. at 1053 (quoting Eldridge v. Eli Lilly & Co., 485 N.E.2d 551, 553 (InI. App.
Ct. 1985)).
92. See id.
93. Coyle v. Richardson-Merrell, Inc., 584 A.2d 1383 (Pa. 1991).
94. See id. at 1384. The plaintiffs were the parents of a child born with mal-
formed limbs allegedly caused by the anti-nausea drug Bendectin, a prescrip-
tion drug manufactured by Merrell Dow. See id.
95. Id. at 1386.
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In other words, requiring pharmacists to warn could confuse
patients. Specifically, such a duty would inteject individuals
who do not have access to patients' medical history into the
drug dispensing process after their physicians already pro-
vided the necessary warnings.96
4. No Liability Under Breach of Warranty Theories
Despite recognizing the pharmacist as a service provider
and not a seller of drugs,97 and acknowledging the majority
view that pharmacists have no duty to warn,98 some courts
nevertheless attempt to apply the Uniform Commercial Code
("U.C.C.") to pharmacist-patient transactions.99 Courts apply
breach of implied and express warranties under the U.C.C. to
impose liability upon pharmacists.'
a. No Liability Under an Express Warranty
Under the express warranty theory, a consumer may hold
a seller liable if the seller expressly warrants that the product
is as promised or described.' °' Holding pharmacists liable un-
der an express warranty theory, however, usually fails."2
Two critical elements of express warranties are not pres-
ent in the normal pharmacist-patient interaction. 3 First, for
an express warranty to apply, the pharmacist must give ex-
press assurances to the patient that the product is not defec-
tive.' Such assurances are rare in the typical pharmacy-
patient interaction.' Second, the necessary "basis of the
96. See id. at 1387.
97. See supra note 48 and accompanying text.
98. See supra Part II.A.3.
99. Article Two of the Uniform Commercial Code (U.C.C.) governs the sale
of goods. It states that a "[sleller means a person who sells or contracts to sell
goods." U.C.C. § 2-103(d) (1978). Additionally, a "sale consists in the passing of
title from the seller to the buyer for a price." U.C.C. § 2-106(1).
100. See Leesley v. West, 518 N.E.2d 758 (Ill. App. Ct. 1988); Batiste v.
American Home Prods. Corp., 231 S.E.2d 269 (N.C. Ct. App. 1977); Makripodis
v. Merrell Dow Pharm., Inc., 523 A.2d 374 (Pa. Super. Ct. 1987).
101. The express warranties provide: "Any affirmation of fact or promise
made by the seller to the buyer which relates to the goods and becomes part of
the basis of the bargain creates an express warranty that the goods shall con-
form to the affirmation or promise." U.C.C. § 2-313(1)(a).
102. See infra note 109.
103. See infra note 109.
104. See U.C.C. § 2-313(1)(a).
105. Since drug companies compound the typical prescription outside of the
pharmacy, a pharmacist cannot assure that the drug is free of defects.
20001 917
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bargain" is seldom established between the pharmacist and
patient. 6 since the pharmacist does not induce the patient to
purchase the medication. Without these two elements of ex-
press warranties, there can be no liability for pharmacists
under an express warranty theory."7
b. No Liability Under an Implied Warranty of
Merchantability
As a result of the difficulty with invoking the express
warranty provision of the U.C.C., some plaintiffs assert
claims based on a theory of implied warranty."8 The implied
warranty of merchantability 9 (i.e., that the goods are fit for
their ordinary purpose) and the implied warranty of fitness..0
(i.e., that the goods are fit for a particular purpose) arise
when goods are sold by a merchant in the business of selling
such goods. Actions against a pharmacist to recover damages
from a defective drug based on these implied warranties
fail."'
Courts reject the implied warranty theories on three dif-
ferent bases. First, the existence of an implied warranty of
fitness for a particular purpose requires a customer's reliance
on the seller's skill and judgment in providing a suitable
product."' Since the patient relies only on the physician's
judgment, no liability arises for the pharmacist based on this
implied warranty."'
106. See U.C.C. § 2-313(1)(a).
107. The main flaw in the "basis of the bargain" theory is that the pharma-
cist does not select the medication for the patient and, as such, is only providing
a service rather than acting as a seller. See Sparks v. Kroger Co., 407 S.E.2d
105 (Ga. Ct. App. 1991).
108. See McCleod v. W.S. Merrell Co., 174 So. 2d 736 (Fla. 1965); Batiste v.
American Home Prods. Corp., 231 S.E.2d 269 (N.C. Ct. App. 1977); Makripodis
v. Merrell Dow Pharm., Inc., 523 A.2d 374 (Pa. Super. Ct. 1987).
109. See U.C.C. § 2-314. The implied warranty of merchantability is defined
as "a warranty that the goods shall be merchantable is implied in a contract for
their sale if the seller is a merchant with respect to goods of that kind." Id.
110. See U.C.C. § 2-315. The implied warranty of fitness states:
Where the seller at the time of contracting has reason to know any par-
ticular purpose for which the goods are required and that the buyer is
relying on the seller's skill or judgment to select or furnish suitable
goods, there is unless excluded or modified under the next section an
implied warranty that the goods shall be fit for such purpose.
Id.
111. See supra note 100.
112. See U.C.C. § 2-315.
113. See, e.g., McCleod, 174 So. 2d at 738; Batiste, 231 S.E.2d at 276.
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Second, there is no single "ordinary purpose""4 to war-
rant a prescription drug. The particular purpose for any drug
depends upon the physician's assessment of the fitness of the
drug for a given patient's medical condition."5 Therefore, a
pharmacist's warranty could only be to ensure that a given
prescription is correctly labeled and dispensed according to
the physician's directions. 16
Finally, courts reject the implied warranty theories by
defining the dispensing pharmacist as a provider of services
and not a seller of drugs."7 As a provider of services, rather
than a merchant of goods, no implied warranty arises as a re-
sult of the sale of a prescription drug."'
B. Pharmacists' Liabilities Increase as Pharmacists' Duties
Expand
Over the last decade, the tradition of granting immunity
to pharmacists who accurately process prescriptions has
eroded."' With this erosion, pharmacists have become recog-
nized as vital, proactive professionals in the health care
field." 
0
Of course, pharmacists must continue to be error-free in
the processing of prescriptions. Furthermore, they must be-
come increasingly prescription "gatekeepers," assuring the
appropriate use of medications and consulting with physi-
cians to clarify and remedy any potential problems with pre-
scribed medications. 2' With this new gatekeeping role, a mi-
nority of courts require pharmacists to provide patients with
appropriate warnings regarding potential adverse conse-
114. See U.C.C. § 2-314(c).
115. See supra note 100.
116. See Makripodis v. Merrell Dow Pharm., Inc., 523 A.2d 374, 377 (Pa. Su-
per. Ct. 1987).
117. See, e.g., Murphy v. E.R. Squibb & Sons, Inc., 710 P.2d 247, 252 (Cal.
1985).
118. See id. at 253.
119. See, e.g., Hooks SuperX, Inc., v. McLaughlin, 642 N.E.2d 514, 519 (Ind.
1994) (recognizing that pharmacists also have a duty to further society's goal of
preventing the overuse and misuse of prescription drugs); Pittman v. Upjohn
Co., 890 S.W.2d. 425, 435 (Tenn. 1994) (finding a pharmacy has a duty to warn
of dangerous drug propensity when no warning had been given by a physician).
120. See Laizure, supra note 61, at 535 (reviewing a higher standard of care
to which professionals are held in their field, and finding pharmacists, as
trained professionals, are held to this professional standard of care).
121. See Lasley v. Shrake's Country Club Pharmacy, Inc., 880 P.2d 1129,
1134 (Ariz. Ct. App. 1994).
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quences of prescription medications.'22
1. Pharmacists Have a Duty to Warn of a Prescription's
Adverse Effects
a. The Dooley Case
In 1990, the Tennessee Court of Appeals departed from
the no-duty-to-warn line of cases."n The plaintiffs in Dooley v.
Everett114 were the parents of a child diagnosed with asthma
who suffered irreversible neurological injuries due to ingest-
ing toxic levels of an asthma medication.' The child took the
asthma medication as dispensed by the defendant pharmacy
for three months, during which time the pharmacy also filled
an antibiotic prescription for the child.126 The package insert
for the antibiotic warned of a possible drug interaction be-
tween the antibiotic and the asthma medication that could
produce toxic levels of the asthma drug.127 The defendant
pharmacy gave no notice or warning to either the physician or
the plaintiffs.128
Evidence presented to the trial court showed that the
pharmacist was unaware of the possible drug interaction or
the serious problems it posed to the patient. Thus, the trial
court granted summary judgment in favor of the pharmacy.'29
The appellate court disagreed, holding that the plaintiffs' evi-
dence was sufficient to withstand summary judgment."
In reversing the trial court, the appellate court relied
heavily on an affidavit by a practicing pharmacist, which set
forth the standard of care for the practice of pharmacy in both
local and similar communities."' This standard of care in-
122. See Guillory v. Dr. X, 679 So. 2d 1004, 1010 (La. Ct. App. 1996) (holding
that a pharmacist has a duty to warn patients or notify the prescribing physi-
cian that the prescription creates substantial risk of harm to the patient).
123. See Pysz v. Henry's Drug Store, 457 So. 2d 561, 562 (Fla. Dist. Ct. App.
1984); Leesley v. West, 518 N.E.2d 758, 763 (Ill. App. Ct. 1988); Adkins v. Mong,
425 N.W.2d 151, 154 (Mich. Ct. App. 1988); Stebbins v. Concord Wrigley Drugs,
Inc., 416 N.W.2d 381, 387-88 (Mich. Ct. App. 1987).
124. Dooley v. Everett, 805 S.W.2d 380 (Tenn. Ct. App. 1990).
125. See id. at 382.
126. See id.
127. See id.
128. See id.
129. See id.
130. See Dooley, 805 S.W.2d at 386.
131. See id. at 382-83.
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cluded (1) maintaining a patient profile system; (2) reviewing
the profile to determine, among other things, if any drugs
would interact with patients' current medications; (3) warn-
ing patients of any possible interactions; and (4) advising pa-
tients of symptoms of toxicity.'32 Based on this expert proof
that the pharmacist negligently failed to warn of the potential
interaction, the appellate court reversed the summary judg-
ment.
b. The Riff Case
In 1986, a Pennsylvania appellate court, in Riff v.
Morgan Pharmacy,3 affirmed a verdict and judgment against
a pharmacy for failure to warn." The court concluded that
the plaintiff stated a valid claim for liability due to the phar-
macist's failure to instruct the patient regarding the maxi-
mum dosage and possible side effects from exceeding that
dosage."5 In fact, the prescription presented to the pharma-
cist did not advise of a maximum safe dosage for a dangerous
and potentially toxic migraine drug."6 The pharmacist accu-
rately filled the prescription and provided the dosage instruc-
tions as written by the physician, without giving any warn-
ings. 3 ' Unaware of any danger, the plaintiff exceeded the
maximum safe dosage and suffered severe injuries. 8  In
holding the pharmacist liable, the court, like the Dooley
court,"9 looked to the professional community to ascertain the
standard of care required of a reasonably prudent pharma-
cist.' The court held that "the testimony of the medical ex-
132. See id. at 383.
133. Riffv. Morgan Pharmacy, 508 A.2d 1247 (Pa. Super. Ct. 1986).
134. See id.
135. See id. at 1253-54.
136. See id. at 1249. The prescription for 12 migraine suppositories (Cafer-
got) read only "insert one every 4 hours for headache" and failed to advise of the
maximum safe dosage of no more than two per migraine attack and no more
than five per week. Id. at 1249-50.
137. See id. at 1249.
138. See id.
139. See Dooley v. Everett, 805 S.W.2d 380, 385 (Tenn. Ct. App. 1990).
140. See Riff, 508 A.2d at 1250-51. The court reasoned:
It is not for this Court to delineate the precise bounds of a medical pro-
fessional's responsibilities. It is for the medical community to deter-
mine what degree of vigilance is required in this respect. They are in
the best position to balance the interests and prescribe a standard of
conduct which is consistant [sic] with the best interests of the patient.
Id. at 1253.
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perts, both physicians and pharmacists, established that the
conduct of... [the] pharmacists fell below the level of reason-
able conduct in the practice of pharmacy."
141
c. The Lasley Case
In a bold 1994 decision, the Arizona Court of Appeals re-
jected outright the traditional no-duty-to-warn argument."4
In Lasley v. Shrake's Country Club Pharmacy, Inc.,' the
court held that a pharmacy owes patients a duty of reason-
able care and that the trial court erred in holding the phar-
macy owed no duty to warn as a matter of law.
14
The pharmacy in Lasley dispensed an addictive medica-
tion to the plaintiff for thirty years without ever informing
the patient of the drug's addictive nature. 5 The pharmacy
denied it owed a duty to warn of the drug's dangerous proper-
ties or to keep track of the patient's reliance on the prescribed
drug.14 The Lasley court disagreed, determining that a ques-
tion existed as to whether a pharmacist's reasonable standard
of care includes the duty to warn of adverse side effects." 7
The Lasley court rejected the approach of earlier no-duty-to-
warn cases 48 and chose to follow the analysis of Dooley.14 The
court determined that the pharmacy did owe the patient a
duty of reasonable care and that failure to warn might consti-
tute a breach of that duty.6 0
2. Voluntary Assumption of the Duty to Warn: The Baker
Case
A Michigan Court of Appeals decision set a new standard
in 1996 by affirming pharmacists' duty to warn in Baker v.
Arbor Drugs, Inc. 5' The patient in Baker had been taking an
141. Id.
142. See Lasley v. Shrake's Country Club Pharmacy, Inc., 880 P.2d 1129,
1134 (Ariz. Ct. App. 1994).
143. Id. at 1129.
144. See id. at 1130.
145. See id. at 1131.
146. See id.
147. See id. at 1132.
148. See supra Part II.A.3.
149. See Dooley v. Everett, 805 S.W.2d 380, 384 (Tenn. Ct. App. 1991) (noting
the distinction between duty and standard of care); see also supra Part II.B.1.a.
150. See Lasley, 880 P.2d at 1129.
151. Baker v. Arbor Drugs, Inc., 544 N.W.2d 727 (Mich. Ct. App. 1996).
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antidepressant medication for several years.'52 The patient
had his cold medications filled at Arbor Drugs, where he also
received his antidepressant medication.' At the time Arbor
Drugs filled the patient's prescriptions for the cold medica-
tions, it had a computerized drug interaction detection system
that detected a serious drug interaction between the antide-
pressant and the cold medications.' The pharmacist claimed
she did not see the interaction indicated on the computer,
probably because a technician overrode the interaction notifi-
cation. 5' Receiving no warnings, the patient took the medica-
tions as prescribed and suffered serious side effects. 55
The issue before the Michigan Court of Appeals was
whether the pharmacy had voluntarily assumed a duty to its
customers to prevent prescription drug interactions.'57 The
Michigan court looked to previous cases but found no disposi-
tive decisions on the issue of pharmacists' duty of care.
58
However, because Arbor Drugs implemented and advertised
its new computerized drug detection system to the public,
claiming the system prevented harmful drug interactions, the
court agreed with the plaintiff that Arbor Drugs voluntarily
assumed a duty of care to its patients."9 The holding in Baker
does not extend to all duty-to-warn cases; however, it encom-
passes those situations where a pharmacist or pharmacy vol-
untarily assumes a duty, then fails to perform that duty with
152. See id. at 729. The patient was taking an antidepressant belonging to a
class of drug (monoamine oxidase inhibitors) that are known to cause severe
complications if taken with certain foods or other medications. See id.
153. See id.
154. See id.
155. See id.
156. See id. at 729. As a direct result of the drug interaction, the patient suf-
fered a stroke, and then committed suicide, claiming in a suicide note that,
among other things, the stroke was too much for him to handle. See id.
157. See Baker, 544 N.W.2d at 729.
158. See id. at 731.
159. See id. The following is an example of the defendant's commercials ad-
vertising its computerized drug interaction detection system:
Do you know what happens when you bring your prescription to Arbor
Drugs? First, it's checked for insurance coverage and screened for pos-
sible drug interactions and therapeutic duplication. That's done very
quickly by the Arbortech Plus computer. Then your prescription is
filled and labelled [sic]. That's done very carefully, by your Arbor
pharmacist. The bottom line? Your prescription is not just filled
quickly, it's filled safely. Only at the Arbor Pharmacies. You can't get
any better.
Id. at 731.
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ordinary care."'
3. OBRA 90: Establishing the Minimum Standard of
Care
In rejecting the traditional no-duty-to-warn standard, the
Dooley, Rift, and Lasley courts focused on determining the
appropriate standard of care expected of professional phar-
macists.61 In doing so, these courts relied on community
standards of pharmacy practice and on expert testimony.6 '
Congress helped to establish pharmacists' minimum stan-
dards of care by passing the Omnibus Budget Reconciliation
Act of 1990,163 which contained provisions affecting how
pharmacists handle prescription processing.'
The goal of OBRA 90, as it relates to pharmacists, is to
improve patient drug therapy by ensuring that prescriptions
are appropriate, medically necessary, and not likely to result
in adverse medical effects. 6' OBRA 90 mandates that phar-
macists take a more active role in drug therapy by inquiring
into patients' conditions, reviewing their relevant medical
history, and performing drug counseling." To carry out this
mandate, OBRA 90 requires each state to provide drug use
review programs to improve the quality of pharmaceutical
care. States must establish drug use review boards, compre-
hensive prospective and retrospective drug reviews performed
by a pharmacist, and require pharmacists to obtain medical
histories on each patient.'67 Finally, OBRA 90 specifically re-
quires pharmacists to discuss with patients the common and
potentially severe side effects of prescribed drugs, as well as
any potential drug interactions."6'
160. See id. at 733 n.1.
161. See supra notes 124, 133, and 142.
162. See supra Part II.B.1.a-c.
163. Omnibus Budget Reconciliation Act of 1990, Pub. L. No. 101-508, 104
Stat. 1388 (codified in scattered sections of 42 U.S.C.).
164. See 42 U.S.C. § 1396r-8(g)(2)(A) (1994).
165. See id. § 1396r-8(g)(1)(A).
166. See id. § 1396r-8(g)(2)(A).
167. See id. § 1396r-8(g)(2)(A)(ii)(II).
168. The specific requirements of this provision of OBRA 90 are:
(I) The pharmacist must offer to discuss with each individual receiving
benefits under this title or caregiver of such individual (in person,
whenever practicable, or through access to a telephone service which is
toll-free for long distance calls) who presents a prescription, matters
which in the exercise of the pharmacist's professional judgment (consis-
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"The OBRA 90 statutes were drafted to provide states
with wide latitude for implementation, however, most have
followed the OBRA 90 requirements." 9 For example, the pa-
tient counseling rules adopted by California are representa-
tive of, and consistent with, the OBRA 90 mandate.7 ' Cali-
fornia requires pharmacists to provide each patient with an
oral consultation that includes "[p]recautions and relevant
warnings, including common severe side or adverse effects or
interactions that may be encountered."' In addition to the
minimum oral consultation requirement, pharmacists must
also advise the patient regarding "[therapeutic contraindica-
tions, avoidance of common severe side or adverse effects or
known interactions, including serious potential interactions
with known nonprescription medications and therapeutic con-
traindications and the action required if such side or adverse
effects or interactions or therapeutic contraindications are
present or occur."'72
Besides establishing a duty to counsel, the California
rules also require pharmacists to maintain medication rec-
ords on all patients. These records must include "patient al-
lergies, idiosyncrasies, current medications and relevant prior
medications including nonprescription medications and rele-
vant devices, or medical conditions," if they relate to drug
therapy. 3 Furthermore, California pharmacists must "re-
tent with State law respecting the provision of such information), the
pharmacist deems significant including the following.
(aa) The name and description of the medication.
(bb) The route, dosage form, dosage, route of administration, and
duration of drug therapy.
(cc) Special directions and precautions for preparation, administra-
tion and use by the patient.
(dd) Common severe side or adverse effects or interactions and
therapeutic contraindications that may be encountered, including
their avoidance, and the action required if they occur.
(ee) Techniques for self-monitoring drug therapy.
(if) Proper storage.
(gg) Prescription refill information.
(hh) Action to be taken in the event of a missed dose.
Id. § 1396r-8(g)(2)(A)(ii).
169. John C. West & David E. Smith, A Prescription for Liability: The Phar-
macy Mandate of the Omnibus Budget Reconciliation Act of 1990 and Its Impact
Upon Pharmacists' Common Law Duties, 2 J. PHARMACY & L. 127, 132 (1994).
170. See CAL. CODE REGS. tit. 16, § 1707.2 (1997).
171. Id. § 1707.2(cX2).
172. Id. § 1707.2(d)(6).
173. Id. § 1707.1(a)(1)(C).
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view the patient's drug therapy and medication record before
each prescription drug is sold."74 California also requires
pharmacists to give notice to their customers that the phar-
macist provides "professional prescription dispensing and pro-
fessional consultation."175
The impact of OBRA 90176 on the duties of pharmacists,
together with the duty-to-warn cases such as Dooley, Riff, and
Lasley, have altered the role of pharmacists. Today, the
pharmacist's job goes beyond merely counting and pouring
medications-pharmacists play an active role as true "health
care professionals."78 OBRA 90 recognized some of these ex-
panded duties by requiring pharmacists to monitor patients'
therapy and consult patients and physicians on optimal ther-
apy.17
9
4. Expanding Pharmacists' Duties in Managed Care
Organizations
A new area of pharmacy, born out of the competitive
forces of health care economics, is the managed care pharma-
cist.18° Managed care organizations ("MCOs") are health care
organizations that attempt to control health care costs by cen-
tralizing health care decisions and restricting the physicians'
treatment choices.' 8 ' One method of restricting physician
choice is through the use of drug formularies, which require
physicians to select drugs from a given list of MCO-approved
174. Id. § 1707.3.
175. Id. § 1707.2(f). The "prominently posted" notice to consumers states:
[Tihis pharmacy shall provide its current retail price of any prescrip-
tion ... prices for the same drug vary from pharmacy to pharmacy.
One reason for differences in price is differences in services provided.
The services provided by this pharmacy, in addition to professional
prescription dispensing and professional consultation, are checked be-
low. In comparing prescription prices it is important to consider the
services provided.
Id.
176. Omnibus Budget Reconciliation Act of 1990, Pub. L. No. 101-508, 104
Stat. 1388 (codified in scattered sections of 42 U.S.C.).
177. See supra notes 124, 133, and 142.
178. See Green, supra note 3, at 1476.
179. See 42 U.S.C. § 1396r-8(g)(2)(A)(ii) (1994).
180. See Richard M. Cooper, Some Effects of the Clinton Health Care Reform
Proposals on Regulated Aspects of the Pharmaceutical Industry, 24 SETON HALL
L. REV. 1260 (1993).
181. See id. at 1264.
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drugs.182 The use of drug formularies by MCOs limits the
physician's role as a learned intermediary who freely selects
from alternative treatments.183
Affecting the lives of more than 100 million patients in
1994, health care through MCOs now represents a significant
portion of pharmacy business."M As members of pharmacy
and therapeutics committees, pharmacists play a vital role in
making drug formulary decisions that promote therapeutic
guidelines and minimize drug benefit expenses.'85 As deci-
sion-makers in MCOs, pharmacists have a significant impact
on limiting the alternative treatment options available to
physicians. 88
In addition to pharmacists' ability to select which drugs
to make available to patients through drug formulary restric-
tions,"'87 pharmacists may, in some states, directly select and
prescribe drug therapy for patients.88 Eleven states grant
pharmacists the limited right to prescribe certain medica-
tions."'89 This new privilege for pharmacists may, in some
cases, challenge the application of the learned intermediary
doctrine. 9 '
III. IDENTIFICATION OF THE PROBLEM
According to the traditional, and still majority, view,
pharmacist liability is restricted to those instances where the
pharmacist made an error processing a prescription.' A
pharmacist is generally immune from liability for injuries re-
sulting from prescription medicines if he or she accurately
filled the prescription.9"
182. See id.
183. See id.
184. See F. Randy Vogenberg & Douglas J. Pisano, Pharmacy and Managed
Care: Legal Issues on the Horizon, DRUG BENEFIT TRENDs, May 1996, at 14.
185. See John D. Jones, How a PBM Develops Its Drug Formulary, DRUG
BENEFIT TRENDs, June 1998, at 37.
186. See Barry R. Furrow, Enterprise Liability for Bad Outcomes From Drug
Therapy: The Doctor, the Hospital, the Pharmacy, and the Drug Firm, 44 DRAKE
L. REv. 377, 433 (1996).
187. See Cooper, supra note 180, at 1264.
188. See Headden et al., supra note 1, at 49.
189. See id.
190. See discussion supra Part ll.A.3.
191. See discussion supra Part HI.A.1.
192. See discussion supra Part II.A.2.
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A few recent cases reject this tradition by finding that
pharmacists have a duty to warn patients of potential adverse
effects of their prescription drugs.9 Relying on the legisla-
tive mandate of OBRA 90' and on an expanded view of
pharmacists' duty, courts have begun to enlarge the limits of
pharmacist liability.'95 This comment addresses whether the
traditional grant of immunity to pharmacists who accurately
fill prescriptions should survive in light of the recent cases
holding that pharmacists have a duty to warn."6 In addition,
with the expanding role of pharmacists in health care today,'97
courts must reassess pharmacist liability in areas such as
strict liability,'98 breach of warranty,199 and duty to warn.'
IV. ANALYSIS
The traditional view of pharmacist liability may be
changing as pharmacists' role in the health care industry
evolves.1 Advances in technology, such as computer systems
that maintain patient profiles and automatically warn of drug
interactions, expand the capabilities and responsibilities of
pharmacists.2 Pharmacists have a responsibility to patients
beyond the mere technical accuracy of prescription order
processing; this responsibility may include a duty to warn.Y
Pharmacists' responsibilities in MCOs (where pharmacists
restrict physician access to medications through the use of
drug formularies)2 4 and as authorized prescribers, may ne-
cessitate revisiting the application of both the learned inter-
mediary doctrine0 5 and breach of warranty theories.0 6
193. See discussion supra Part II.B.1.
194. Omnibus Budget Reconciliation Act of 1990, Pub. L. No. 101-508, 104
Stat. 1388 (codified in scattered sections of 42 U.S.C.).
195. See discussion supra Part II.B.1.
196. See Lasley v. Shrake's Country Club Pharmacy, Inc., 880 P.2d 1129
(Ariz. Ct. App. 1994); Riff v. Morgan Pharmacy, 508 A.2d 1247 (Pa. Super. Ct.
1986); Dooley v. Everett, 805 S.W.2d 380 (Tenn. Ct. App. 1990).
197. See discussion infra Part IV.
198. See discussion infra Part 1V.B.
199. See discussion infra Part IV.D.
200. See discussion infra Part IV.C.
201. See Laizure, supra note 61, at 535 (noting professionals, including
pharmacists, are held to a higher standard of care in their fields because of
their superior knowledge).
202. See id.
203. See supra Part II.B.1.
204. See supra Part II.B.4.
205. See supra Part II.A.3.
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A. No Strict Liability for Traditional Pharmacists
Viewing pharmacists as service providers and not sellers
of medications, some courts refuse to apply strict liability to
pharmacists.2 07 The rationale behind this argument is that a
service provider is not subject to liability as a supplier under
the Restatement (Second) of Torts."8 In Coyle v. Richardson-
Merrell, Inc.,0 9 which involved birth defects caused by a pre-
scription medicine, the Pennsylvania Supreme Court declined
to extend the rule of strict liability to pharmacists. 10
The Coyle court ruled against application of the Restate-
ment's standard when considering a pharmacist's role as a
supplier of prescription drugs.2 "' The court found strict li-
ability inapplicable to pharmacists because the distribution
system of prescription drugs is a restricted market.212 In such
a market, the patient does not rely on the pharmacist to ob-
tain the products.1 The patient relies only on the physician
to order the medication and assess the risks and benefits in-
herent in the prescription drug.2 4 The court also stated that
holding pharmacists strictly liable provides no safety incen-
tive because pharmacists cannot substitute their judgment
for that of the physician.215
206. See supra Part H.A.4.
207. See Leesley v. West, 518 N.E.2d 758, 762 (IlM. App. Ct. 1988); Kampe v.
Howard Stark Profl Pharmacy, Inc., 841 S.W.2d 223 (Mo. Ct. App. 1992); Ba-
tiste v. American Home Prods. Corp., 231 S.E.2d 269, 275 (N.C. Ct. App. 1977).
208. See Coyle v. Richardson-Merrell, Inc., 584 A.2d 1383, 1386 (Pa. 1991).
Section 402A of the Restatement states:
One who sells any product in a defective condition unreasonably dan-
gerous to the user or consumer or to his property is subject to liability
for physical harm thereby caused to the ultimate user or consumer, or
to his property if a) the seller is engaged in the business of selling such
product, and b) it is expected to and does reach the user or consumer
without substantial change in the condition in which it is sold.
RESTATEMENT (SEcoND) OF TORTS § 402A (1965).
209. Coyle, 584 A.2d at 1383.
210. See id. at 1385.
211. See id. at 1387.
212. See id.
213. See id.
214. See id.
215. See Coyle, 584 A.2d at 1387.
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B. Strict Liability Applicable for the Pharmacist's Expanded
Role
In light of pharmacists' expanding responsibilities, the
criticisms of strict liability for pharmacists are less convinc-
ing today.216 The classification of a pharmacist as only a
service provider and not a seller is arguably incorrect. Under
OBRA 90, pharmacists' obligations include monitoring drug
therapies, discussing drug risks with patients, detecting po-
tential drug interactions, and intervening when necessary to
optimize patient care." Pharmacists' role in MCOs, devel-
oping and enforcing drug formularies, indirectly involves
them in drug selection for patients.1 8 Patients no longer rely
solely on physicians to select drug therapy."9 Patients must
now also rely on pharmacists' skills in determining which
drugs are available for physicians' to select."' Finally, phar-
macists' duties even include prescribing drugs in some juris-
dictions.22' These changes clearly reflect pharmacists' greater
involvement in drug selection and drug sales.222 As pharma-
cists' role in health care continues to expand,23 categorizing
pharmacists as service providers and not sellers, in order to
avoid strict liability, is no longer valid.224
C. The Pharmacist's Duty to Warn of a Drug's Potential
Hazards
In addition to the traditional view that pharmacists are
not subject to strict liability, most courts continue to hold that
pharmacists also have no duty to warn patients of potential
hazards of prescription drugs.2" While pharmacists still have
an absolute duty to fill prescriptions accurately and be alert
for obvious or patent errors on the face of prescriptions,
pharmacists do not have a duty to question the judgment of
physicians as to the propriety of prescriptions.226
216. See supra Part II.B.
217. See supra Part II.B.3.
218. See supra Part H.B.4.
219. See supra Part I.B.4.
220. See Cooper, supra note 180, at 1264.
221. See Headden et al., supra note 1, at 46.
222. See Cooper, supra note 180, at 1264.
223. See supra Part II.B.4.
224. See supra Part II.A.2.
225. See supra Part II.A.3.
226. See, e.g., McKee v. American Home Prods. Corp., 782 P.2d 1045 (Wash.
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The courts in McKee v. American Home Products Corp. 27
and Adkins v. Mong2' held that pharmacists owed no duty to
warn customers of the potential hazards associated with pre-
scribed drugs. These cases relied upon the traditional role of
the pharmacist as a service provider and held that the duty to
warn should remain with the physician.2 9
More recent cases, however, find that pharmacists do
have a duty to warn of the potential hazards of drugs."0 In
Dooley v. Everett, 1 the court looked to the appropriate stan-
dard of care for pharmacists, and stated: "The fact that the
pharmacy owes its customers a duty in dispensing prescrip-
tion drugs is without question." 2 The court also noted that
"one who undertakes to render services in the practice of a
profession or trade is required to exercise skill and knowledge
normally possessed by members of that profession or trade in
good standing in similar communities." 3 The court reasoned:
Duty is a question of whether the defendant is under any
obligation for the benefit of the particular plaintiff; and in
negligence cases, the duty is always the same-to conform
to the legal standard of reasonable conduct in the light of
the apparent risk. What defendant must do or must not
do, is a question of the standard of conduct required to
satisfy the duty. The distinction is one of convenience
only, and it must be remembered that the two are correla-
tive, and one cannot exist without the other. 4
The Dooley court also found the learned intermediary
doctrine inapplicable based on pharmacists' duty to their cus-
tomers. The court held that pharmacists owe their customers
a duty of reasonable care in filling prescriptions, but left it to
the trier of fact to determine what level of care is required. 5
1989).
227. Id.
228. Adkins v. Mong, 425 N.W.2d 151 (Mich. Ct. App. 1988).
229. See id. at 154; McKee, 782 P.2d at 1051-54.
230. See supra Part II.B.1.
231. Dooley v. Everett, 805 S.W.2d 380 (Tenn. Ct. App. 1990).
232. Id. at 386.
233. Id. at 385 (citing RESTATEMENT (SECOND) OF TORTS § 299A (1965)).
234. Id. at 384 (quoting W. PAGE KEETON ET AL., PROSSER AND KEETON ON
THE LAW OF TORTS § 53, at 356 (5th ed. 1984)).
235. See id. at 386.
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In Riff v. Morgan Pharmacy,36 the court stated that a
pharmacist, as a trained professional, has "an affirmative
duty to read the prescription and to be aware of patent inade-
quacies in the instructions." 7 According to the court:
Fallibility is a condition of human existence. Doctors, like
other mortals, will from time to time err through igno-
rance or inadvertance [sic]. An error in the practice of
medicine can be fatal; and so it is reasonable that the
medical community including physicians, [and] pharma-
cists . .. have established professional standards which
require vigilance not only with respect to primary func-
tions, but also regarding the acts and ommissions [sic] of
the other professionals and support personnel in the
health care team. Each has an affirmative duty to be, to a
limited extent, his brother's keeper.2
In Lasley v. Shrake's Country Club Pharmacy, Inc.,39 the
Arizona Court of Appeals continued the Dooley and Riff trend
by also rejecting the earlier no-duty-to-warn cases.24 The
court cautioned against confusing duty with the applicable
standard of conduct and explained: "Specific details of con-
duct do not determine whether a duty exists but instead bear
on whether a defendant who owed a duty to the plaintiff
breached the applicable standard for care.""4 The court con-
cluded that the defendant pharmacy in Lasley owed the pa-
tient a duty of reasonable care and remanded the case for the
trier of fact to determine the appropriate standard of care.242
The crux of the Lasley decision was that prior courts had
confused the concept of duty with that of the standard of
care."' Lasley declared that pharmacists owe their patients a
duty of reasonable care commensurate with their profes-
sion.' However, despite the use of expert testimony to help
establish the pharmacist's standard of care, the precise scope
236. Riffv. Morgan Pharmacy, 508 A.2d 1247 (Pa. Super. Ct. 1986).
237. Id. at 1253.
238. Id.
239. Lasley v. Shrake's Country Club Pharmacy, Inc., 880 P.2d 1129 (Ariz.
Ct. App. 1994).
240. See id. at 1134.
241. Id. at 1132 (quoting Markowitz v. Arizona Parks Board, 706 P.2d 364
(Ariz. 1985)).
242. See id. at 1134.
243. See id. at 1132.
244. See id.
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of that standard continues to perplex courts.24 The minimum
scope of duty, however, has now been legislatively established
with the enactment of OBRA 90.246
1. OBRA 90: Establishing a Minimum Standard of Care
OBRA 90's goal for pharmacists is to improve patient
drug therapy and decrease the cost of caring for patients. 7
OBRA 90 requires pharmacists to take a more active role in
patient care by inquiring into patients' conditions, maintain-
ing a medical history profile for each patient, and performing
drug counseling prior to dispensing medications.' While the
policy goals of OBRA 90 may be desirable, the OBRA 90 pro-
visions nevertheless place additional liability upon pharma-
cists. 249 In addition to the effects of OBRA 90 on strict liabil-
ity analysis," ° pharmacists now appear to have a legislatively
mandated duty to warn."'
Earlier courts such as McKee and Adkins shielded phar-
macists from liability for the duty to warn by holding that (1)
pharmacists lacked an understanding of, and access to, pa-
tients' medical history; (2) pharmacists had no duty to moni-
tor and intervene with patients' ongoing treatment; and (3)
requiring pharmacists to warn would interfere with the doc-
tor-patient relationship. u2 OBRA 90's mandated changes in
the pharmacist's duties, however, now negate the force of
these arguments. 3
Under OBRA 90, pharmacists must obtain, record, and
maintain patients' medical histories. 4 The medical history
must include disease states, 5 allergies, drug reactions, and a
245. See, e.g., Green, supra note 3, at 1477.
246. Omnibus Budget Reconciliation Act of 1990, Pub. L. No. 101-508, 104
Stat. 1388 (codified in scattered sections of 42 U.S.C.).
247. See 42 U.S.C. § 1396r-8(g)(1)(A) (1994).
248. See supra Part II.B.3.
249. See Brenda Jones Quick, The Cost of the Omnibus Budget Reconciliation
Act of 1990, 2 J. PHARMACY & L. 145 (1994).
250. See supra Part IV.B.
251. See 42 U.S.C. § 1396r-8(g)(2)(A)(ii).
252. See Adkins v. Mong, 425 N.W.2d 151, 154 (Mich. Ct. App. 1988); McKee
v. American Home Prods. Corp., 782 P.2d 1045, 1049 (Wash. 1989).
253. See Omnibus Budget Reconciliation Act of 1990, Pub. L. No. 101-508,
104 Stat. 1388 (codified in scattered sections of 42 U.S.C.).
254. See id.
255. Disease states are medical conditions such as diabetes, hypertension,
and AIDS.
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comprehensive list of patients' current medications.256 Using
this medical history, pharmacists are required by OBRA 90 to
assess the propriety of each new prescription drug and offer
to discuss with patients any significant matters, including di-
rections, dosage, precautions, use, and any potentially signifi-
cant side effect or interactions.25 Instead of applying the
learned intermediary doctrine and shielding pharmacists
from liability, courts must consider the pharmacist the new
learned intermediary and impose liability for the failure to
warn.
25 8
2. Assumption of the Duty to Warn: The Baker Case
While OBRA 90 helps to establish the minimum standard
of care required of pharmacists, Baker v. Arbor Drugs, Inc. 9
established a duty of care when pharmacists voluntarily as-
sume a duty to monitor for adverse drug interactions.2  In
Baker, the Michigan Court of Appeals concluded that when a
pharmacy implements and advertises that its new computer-
ized drug detection system prevents harmful drug interac-
tions, the pharmacy owes a duty of care to its customers to
identify and prevent drug interactions.261 Although the Baker
decision did not discuss the minimum standard of care phar-
macists owe to patients in general, the decision addressed
those instances where a pharmacy voluntarily assumes a
duty to warn."' The court correctly held that a duty to warn
exists whenever a pharmacy voluntarily assumes this duty.6 3
California may also have opened the doors of litigation to
pharmacists' assumption of duty when it implemented the
mandates of OBRA 90.'2 California requires pharmacists not
only to provide drug consultation to patients, but also to no-
tify their customers of the professional consultation available
by prominently displaying a notice of the services provided."6 '
256. See 42 U.S.C. § 1396r-8(gX2)(A)(ii).
257. See id.
258. See, e.g., Gibbs & Mackler, supra note 49 (explaining the rationale of a
learned intermediary).
259. Baker v. Arbor Drugs, Inc., 544 N.W.2d 727 (Mich. Ct. App. 1996).
260. See id. at 731.
261. See id.
262. See id.
263. See id.
264. See CAL. CODE REGS. tit. 16, § 1707.2 (1997).
265. See id. § 1707.2(f).
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By notifying their customers of this service, a pharmacy, like
the pharmacy, in Baker, may be liable for assumption of the
duty to warn. 6
D. Pharmacists May Be Liable Under Breach of Warranty
Theories
Just as OBRA 90 and pharmacists' expanding role in
health care delivery6 7 affect the analysis of pharmacy liability
in duty-to-warn!' and strict liability cases,26 9 courts must also
reevaluate the breach of warranty analysis. 27" Liability under
express warranty theory has not applied to pharmacists be-
cause, traditionally, pharmacists gave no express assurances
in the typical pharmacy-patient interaction and no basis of
the bargain could be established between patients and phar-
macists. 71 Though courts generally find no liability under
breach of warranty theories,272 the justifications for the failure
to apply the breach of warranty are no longer persuasive.273
First, as the role of the pharmacist expands, express as-
surances may now occur.274 As pharmacists become more in-
volved in MCOs and drug formulary selection, they indirectly
select medications for patients by limiting physicians'
choices. 275 Additionally, courts may view OBRA 90's mandate
that the pharmacist monitor and intervene when necessary
into a patient's drug therapy as an assurance to patients that
the pharmacist will use sound clinical judgment to ensure op-
timum drug therapy.276 Second, if a patient relies on a phar-
macist's professional judgment when selecting the medica-
tions to allow on the drug formulary, and on a pharmacist's
266. See Baker v. Arbor Drugs, Inc., 544 N.W.2d 727, 731 (Mich. Ct. App.
1996).
267. See Omnibus Budget Reconciliation Act of 1990, Pub. L. No. 101-508,
104 Stat. 1388 (codified in scattered sections of 42 U.S.C.).
268. See Laizure, supra note 61, at 522-26.
269. See discussion supra Part 1V.A-B.
270. See discussion supra Part II.A.4.
271. See McCleod v. W.S. Merrell Co., 174 So. 2d 736 (Fla. 1965); Batiste v.
American Home Prods. Corp., 231 S.E.2d 269 (N.C. Ct. App. 1977); Makripodis
v. Merrell Dow Pharm., Inc., 523 A.2d 374 (Pa. Super. Ct. 1987).
272. See Leesley v. West, 518 N.E.2d 758 (Ill. App. Ct. 1988); Batiste, 231
S.E.2d at 269; Makripodis, 523 A.2d at 374.
273. See discussion supra Part H.A.4.
274. See Lasley v. Shrake's Country Club Pharmacy, Inc., 880 P.2d 1129
(Ariz. Ct. App. 1994).
275. See Furrow, supra note 186, at 433.
276. See 42 U.S.C. § 1396r-8(g)(2)(A) (1994).
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clinical skills to monitor and intervene,277 then a basis of the
bargain is also established.78
Similarly, plaintiffs may now invoke liability on an im-
plied warranty theory.279 First, patients no longer rely only on
a physician's judgment for drug product selection.' Patients
now also rely on pharmacists because of pharmacists' in-
volvement in drug product selection through formulary re-
strictions and direct prescribing.28' Second, although the par-
ticular purpose for any drug prescribed still depends on the
physician's judgmente2 (unless the pharmacist is acting as a
prescriber 83), pharmacists also indirectly select the drug for a
particular purpose by limiting the available drugs on the for-
mularies.2" Third, based on the fact that pharmacists now
participate in drug product selection, pharmacists now also
satisfy the requirement of being merchants of those selected
drugs for the purposes of implied warranty.' Thus, for both
express and implied warranty theories, the expanding role of
pharmacists in health care delivery weakens the arguments
against imposing liability. 6
V. PROPOSAL
Pharmacists' traditional role in the health care arena fo-
cused solely on drug distribution and the accurate dispensing
of medications to the customer.287 The majority of courts held
pharmacists not liable for injuries resulting from prescribed
medications that were accurately dispensed.288 Since physi-
cians were the only medical professionals with access to pa-
277. See discussion supra Part H.B.3-4.
278. See Sparks v. Kroger Co., 407 S.E.2d 105 (Ga. Ct. App. 1991).
279. See U.C.C. § 2-314 to -315 (1978).
280. See Cooper, supra note 180, at 1264.
281. See id.
282. See McCleod v. W.S. Merrell Co., 174 So. 2d 736 (Fla. 1965); Batiste v.
American Home Prods. Corp., 231 S.E.2d 269 (N.C. Ct. App. 1977); Makripodis
v. Merrell Dow Pharm., Inc., 523 A.2d 374 (Pa. Super. Ct. 1987).
283. See Headden et al., supra note 1, at 46.
284. See Jones, supra note 185, at 37.
285. See Murphy v. E.R. Squibb & Sons, Inc., 710 P.2d 247 (Cal. 1985).
286. See supra Part II.B.4.
287. See Brushwood, supra note 32, at 443.
288. See, e.g., Leesley v. West, 518 N.E.2d 758, 762 (Iil. App. Ct. 1988);
Kampe v. Howard Stark Profl Pharmacy, Inc., 841 S.W.2d 223 (Mo. Ct. App.
1992); Batiste v. American Home Prods. Corp., 231 S.E.2d 269, 275 (N.C. Ct.
App. 1977).
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tients' health history and, therefore, the learned intermedi-
aries, physicians effectively insulated pharmacists and manu-
facturers from liability. 9 These traditional stereotypes are
no longer accurate and the courts should abandon the limits
of liability traditionally afforded pharmacists.29
Pharmacists today are involved in the drug selection pro-
cess and thus courts should consider pharmacists sellers of
drugs as well as service providers."' Such a distinction could
result in strict liability for pharmacists. Under OBRA 90,
pharmacists must now monitor patients' drug therapy and,
when necessary, intervene to recommend changes to that
drug therapy.292 In addition, pharmacists select which medi-
cations are available for patient use through their involve-
ment with drug formulary development.293 Finally, in some
jurisdictions, pharmacists may prescribe drugs, which re-
quires patients to rely on pharmacists to obtain their medica-
tion.294 Thus, strict liability may be appropriate against
pharmacists in certain circumstances.
For similar reasons, courts should reevaluate pharmacist
liability under breach of warranty theories.9 The increased
role pharmacists play in health care today significantly
weakens the arguments limiting liability under breach of
warranty theories.9 Pharmacists today select drug products
through drug formulary development and direct prescrib-
ing. 9 ' Patients must now rely on both pharmacists' judgment
in allowing and excluding certain drugs from formularies, as
well as physicians' judgment in selecting from the limited op-
tions available.299 Finally, patients will rely on pharmacists'
289. See Pysz v. Henry's Drug Store, 457 So. 2d 561, 562 (Fla. Dist. Ct. App.
1984); Leesley, 518 N.E.2d at 763; Adkins v. Mong, 425 N.W.2d 151, 154 (Mich.
Ct. App. 1988); Stebbins v. Concord Wrigley Drugs, Inc., 416 N.W.2d 381, 387-
89 (Mich. Ct. App. 1987).
290. See discussion supra Part II.B.
291. See Headden et al., supra note 1, at 49.
292. See Omnibus Budget Reconciliation Act of 1990, Pub. L. No. 101-508,
104 Stat. 1388 (codified in scattered sections of 42 U.S.C.).
293. See Harry DeMonaco, Health Outcomes and Formulary Concerns,
INFECTIONS MED., 13B, at 36 (Supp. 1996). "In general, formularies provide
cost minimization. For the most part, they are not constructed for quality-of-
cure issues but simply for cost-of-care considerations." Id. at 37.
294. See Headden et al., supra note 1, at 49.
295. See discussion supra Part IV.D.
296. See Furrow, supra note 186, at 433.
297. See Vogenberg & Pisano, supra note 184, at 14.
298. See id.
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consultation with respect to the risks and benefits of drug
therapy, and as a basis of the bargain when purchasing medi-
cations 9
The majority approach of not holding pharmacists liable
for failure to warn of a drug's potential hazards has already
been attacked."' The 1993 implementation of OBRA 901
now sets the minimum standard of care for pharmacists, in-
cluding duties to monitor, intervene, and counsel.0 2 At a
minimum, courts should hold pharmacists to a standard of
care consistent with OBRA 90's mandate. In addition, courts
should remain flexible in setting this minimum standard of
care as the role of pharmacists continues to expand in health
care and pharmacists assume greater responsibilities in en-
303suring competent patient care.
VI. CONCLUSION
The role of the pharmacist in the health care industry
has evolved from merely counting and pouring, to an active
role as a gatekeeper in the drug therapy process.0 4 As drug
therapy becomes more complex and managed care changes
the relationship between physicians and patients, the role
pharmacists play as "drug counselors" becomes more impor-
tant.0 5 The minimum standards set by OBRA 90, combined
with the computerized records of patients' medical histories
and drug regimens, yield realistic expectations for greater re-
sponsibilities of pharmacists.0 0
Moreover, pharmacists are involved in drug product se-
lection through managed care organizations and those or-
ganizations' use of drug formularies."7 Pharmacists must
monitor patients' medical histories, identify problems with
drug therapy, intervene when necessary to prevent harm, and
299. See Lasley v. Shrake's Country Club Pharmacy, Inc., 880 P.2d 1129
(Ariz. Ct. App. 1994).
300. See Leesley v. West, 518 N.E.2d 758, 762 (IM. App. Ct. 1988); Kampe v.
Howard Stark Profl Pharmacy, Inc., 841 S.W.2d 223 (Mo. Ct. App. 1992); Ba-
tiste v. American Home Prods. Corp., 231 S.E.2d 269, 275 (N.C. Ct. App. 1977).
301. Omnibus Budget Reconciliation Act of 1990, Pub. L. No. 101-508, 104
Stat. 1388 (codified in scattered sections of 42 U.S.C.).
302. See id.
303. See Green, supra note 3, at 1468.
304. See id. at 1474-75.
305. See Furrow, supra note 186, at 433.
306. See discussion supra Part II.E.4.
307. See Jones, supra note 185, at 37.
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counsel patients to decrease the risk of side effects and in-
crease the benefits of drug therapy.38 As the pharmacist's
role in health care continues to expand, the justifications for
limiting pharmacist liability become less persuasive."9
Pharmacists are a vital link in health care delivery today.
The public's reliance on the pharmacy profession increases as
the public becomes aware of the pharmacist's greater role.
Courts should recognize these new responsibilities by holding
pharmacists legally responsible when reasonably preventable
harm occurs.
308. See West & Smith, supra note 169, at 132.
309. See discussion supra Part lI.B.3-4.
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